GlassScriptPhysician profile
Vicki Kalen
NPI 1073588547
$936.16
in general payments reported to CMS, 2019-2025
21 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Pediatric Surgery provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2022: $178 · 2023: $175 · 2024: $247 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Tezspire |
| Novartis Pharmaceuticals Corporation | $122.07 | 2024 | |
| Hologic Sales and Service, LLC | $111.89 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Stryker Corporation | $109.50 | 2025 | Flowtriever |
| Nalu Medical, INC. | $105.35 | 2023 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $92.99 | 2022 | |
| Silk Road Medical, INC. | $86.96 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $84.96 | 2022 | |
| Integra Lifesciences Corporation | $49.66 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Secura Bio, INC. | $27.75 | 2019 | |
| Mylan Specialty L.P. | $20.03 | 2023 | Yupelri |
10 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicki Kalen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.